Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bron

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Blood|March 13, 2012
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantationWendy Cuccuini, Josette Briere, Nicolas Mounier, et al.
Journal of Clinical Medicine|March 8, 2020
The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal CellsKarolien Buyl, Makram Merimi, Robim M Rodrigues, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trialsElizabeth C Moser, Evert M Noordijk, Patrice Carde, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.
BMC Cancer|January 19, 2019
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patientsVu Luan Dang Chi, Soizic Garaud, Pushpamali De Silva, et al.
Blood|December 1, 2016
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHDGérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, et al.
Frontiers in Cell and Developmental Biology|February 12, 2024
Treatment of medication-related osteonecrosis of the jaw with cell therapyCyril Lucien Bouland, Rokneddine Javadian, Sarah Gilis, et al.
Bulletin Du Cancer|April 9, 2008
[Cord blood: from bench to bedside]Dominique Bron, Cécile De Bruyn, H Balasse, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Blood|March 13, 2012
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantationWendy Cuccuini, Josette Briere, Nicolas Mounier, et al.
Journal of Clinical Medicine|March 8, 2020
The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal CellsKarolien Buyl, Makram Merimi, Robim M Rodrigues, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trialsElizabeth C Moser, Evert M Noordijk, Patrice Carde, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.
BMC Cancer|January 19, 2019
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patientsVu Luan Dang Chi, Soizic Garaud, Pushpamali De Silva, et al.
Blood|December 1, 2016
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHDGérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, et al.
Frontiers in Cell and Developmental Biology|February 12, 2024
Treatment of medication-related osteonecrosis of the jaw with cell therapyCyril Lucien Bouland, Rokneddine Javadian, Sarah Gilis, et al.
Bulletin Du Cancer|April 9, 2008
[Cord blood: from bench to bedside]Dominique Bron, Cécile De Bruyn, H Balasse, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Pageof 17